Patents Assigned to Bioadvantex Pharma Inc.
  • Patent number: 6670392
    Abstract: The invention provides a composition and method for the prevention or treatment of mammalian prostate carcinoma using Vitamin E or Vitamin E derivatives or Vitamin E analogs and selenium or selenium salt or selenium derivatives in a combined or an uncombined form, alone or in combination with traditional therapies. The invention also provides a composition and method for the prevention or treatment of mammalian prostate carcinoma using Vitamin E or Vitamin E derivatives or Vitamin E analogs and selenium or selenium salt or selenium derivatives in a combined or an uncombined form, alone or in combination with traditional therapies to increase the levels of intracellular p21 and/or p27.
    Type: Grant
    Filed: April 6, 2001
    Date of Patent: December 30, 2003
    Assignee: Bioadvantex Pharma Inc.
    Inventor: Neil E. Fleshner